Beaird Harris Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $568K | Buy |
3,060
+31
| +1% | +$5.75K | 0.04% | 86 |
|
|
2025
Q1 | $635K | Sell |
3,029
-96
| -3% | -$20.1K | 0.05% | 73 |
|
|
2024
Q4 | $555K | Buy |
3,125
+393
| +14% | +$69.8K | 0.05% | 82 |
|
|
2024
Q3 | $539K | Buy |
2,732
+675
| +33% | +$133K | 0.05% | 84 |
|
|
2024
Q2 | $353K | Sell |
2,057
-56
| -3% | -$9.61K | 0.03% | 95 |
|
|
2024
Q1 | $385K | Buy |
2,113
+191
| +10% | +$34.8K | 0.04% | 83 |
|
|
2023
Q4 | $298K | Buy |
1,922
+46
| +2% | +$7.13K | 0.03% | 87 |
|
|
2023
Q3 | $280K | Buy |
1,876
+77
| +4% | +$11.5K | 0.03% | 80 |
|
|
2023
Q2 | $242K | Buy |
1,799
+5
| +0.3% | +$674 | 0.03% | 89 |
|
|
2023
Q1 | $286K | Sell |
1,794
-64
| -3% | -$10.2K | 0.05% | 75 |
|
|
2022
Q4 | $300K | Buy |
1,858
+73
| +4% | +$11.8K | 0.06% | 71 |
|
|
2022
Q3 | $240K | Buy |
1,785
+462
| +35% | +$62.1K | 0.05% | 72 |
|
|
2022
Q2 | $203K | Sell |
1,323
-1,252
| -49% | -$192K | 0.06% | 67 |
|
|
2022
Q1 | $417K | Buy |
2,575
+4
| +0.2% | +$648 | 0.15% | 52 |
|
|
2021
Q4 | $348K | Buy |
+2,571
| New | +$348K | 0.13% | 79 |
|